Published in Thromb Res on January 13, 2011
Weight loss and achievement of minimal disease activity in patients with psoriatic arthritis starting treatment with tumour necrosis factor α blockers. Ann Rheum Dis (2013) 1.07
Current and former smoking and risk for venous thromboembolism: a systematic review and meta-analysis. PLoS Med (2013) 1.01
Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol (2013) 1.00
Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Res Ther (2012) 0.90
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. Arterioscler Thromb Vasc Biol (2014) 0.84
Haemostatic and fibrinolytic changes in obese subjects undergoing bariatric surgery: the effect of different surgical procedures. Blood Transfus (2014) 0.77
Direct oral anticoagulants for the treatment of unprovoked venous thromboembolism: a meta-analysis of randomised controlled trials. Blood Transfus (2014) 0.75
The impact of concomitant diffuse idiopathic skeletal hyperostosis on the achievement of minimal disease activity in subjects with psoriatic arthritis. Rheumatol Int (2015) 0.75
Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer. World J Gastroenterol (2017) 0.75
Benign infantile familial convulsions. Eur J Pediatr (1992) 2.46
Genetic modulation of oral anticoagulation with warfarin. Thromb Haemost (2000) 1.67
Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest (2000) 1.60
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Mortality and causes of death in Italian persons with haemophilia, 1990-2007. Haemophilia (2010) 1.59
Expression of interleukin-1beta in human breast carcinoma. Cancer (1997) 1.52
Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations. Am J Obstet Gynecol (1998) 1.49
Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex. Blood (1983) 1.44
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Mesorectum, is it an appropriate term? Int J Colorectal Dis (2007) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Measuring plasma fibrinogen to predict stroke and myocardial infarction: an update. Arterioscler Thromb Vasc Biol (1999) 1.25
Increased risk for venous thrombosis in carriers of the prothrombin G-->A20210 gene variant. Ann Intern Med (1998) 1.20
Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Am J Med (1985) 1.15
The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost (1998) 1.13
Challenges in the prevention of venous thromboembolism in the elderly. J Thromb Haemost (2004) 1.12
Factor V Leiden is associated with repeated and recurrent unexplained fetal losses. Thromb Haemost (1997) 1.11
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. Diabetes (1999) 1.11
Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism. Thromb Haemost (1999) 1.09
Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe. Arterioscler Thromb Vasc Biol (2002) 1.08
Pontocerebellar hypoplasia: clinical, pathologic, and genetic studies. Neurology (2010) 1.07
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Hepatitis C virus infection in Italian intravenous drug users: epidemiological and clinical aspects. Liver (1995) 1.07
Transcriptional profiling of azole-resistant Candida parapsilosis strains. Antimicrob Agents Chemother (2011) 1.06
Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost (1997) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica (2001) 1.03
Homocysteine, coagulation, platelet function, and thrombosis. Semin Thromb Hemost (2000) 1.02
The PAI-1 gene locus 4G/5G polymorphism is associated with a family history of coronary artery disease. Arterioscler Thromb Vasc Biol (1998) 1.02
Association of plasminogen activator inhibitor (PAI)-1 (SERPINE1) SNPs with myocardial infarction, plasma PAI-1, and metabolic parameters: the HIFMECH study. Arterioscler Thromb Vasc Biol (2007) 1.02
The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events. Thromb Haemost (2000) 1.01
A myeloma paraprotein with specificity for platelet glycoprotein IIIa in a patient with a fatal bleeding disorder. J Clin Invest (1986) 1.01
Startle disease: an avoidable cause of sudden infant death. Lancet (1989) 1.00
The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study. J Thromb Haemost (2003) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler Thromb Vasc Biol (1998) 0.99
Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high-responding inhibitors. J Thromb Haemost (2009) 0.98
Oxidative stress and platelet activation in homozygous homocystinuria. Circulation (2001) 0.98
Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. J Clin Invest (1985) 0.97
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann Nutr Metab (2005) 0.97
Trial of repeated low-dose aspirin in diabetic angiopathy. Blood (1986) 0.96
Cost of care of haemophilia with inhibitors. Haemophilia (2009) 0.96
Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient. J Clin Pharm Ther (2010) 0.95
Distal infantile spinal muscular atrophy associated with paralysis of the diaphragm: a variant of infantile spinal muscular atrophy. Am J Med Genet (1989) 0.94
Prostaglandins as inhibitors of human platelet aggregation. Br J Haematol (1979) 0.94
Infantile ascending hereditary spastic paralysis (IAHSP): clinical features in 11 families. Neurology (2003) 0.94
An alternative method for PAI-1 promoter polymorphism (4G/5G) typing. Thromb Haemost (1997) 0.93
Large pituitary hyperplasia in severe primary hypothyroidism. J Clin Endocrinol Metab (2011) 0.92
The use of antithrombotic drugs in older people. Minerva Med (2002) 0.92
Diabetes, vascular complications and antiplatelet therapy: open problems. Acta Diabetol (2008) 0.91
Monitoring the entry of new platelets into the circulation after ingestion of aspirin. Blood (1983) 0.90
Multiple ways to manage portal thrombosis during liver transplantation: surgical techniques and outcomes. Transplant Proc (2013) 0.90
Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen. J Lab Clin Med (1986) 0.89
Plasma homocysteine and microvascular complications in type 1 diabetes. Nutr Metab Cardiovasc Dis (2000) 0.89
Continuous care in the treatment of obesity: an observational multicentre study. J Intern Med (2005) 0.88
A clinical-morphological study on cholestatic presentation of nonalcoholic fatty liver disease. Dig Dis Sci (2005) 0.88
Magnetic resonance imaging and ultrasound evaluation of "healthy" joints in young subjects with severe haemophilia A. Haemophilia (2013) 0.87
Anticardiolipin antibodies in patients with liver disease. Am J Gastroenterol (1999) 0.87
Stapled haemorrhoidopexy vs. Milligan-Morgan haemorrhoidectomy for grade III haemorrhoids: a randomized clinical trial. G Chir (2012) 0.87
Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden. Arterioscler Thromb Vasc Biol (1999) 0.87
Plasminogen activator inhibitor-1 (PAI-1) antigen plasma levels in subjects attending a metabolic ward: relation to polymorphisms of PAI-1 and angiontensin converting enzyme (ACE) genes. Arterioscler Thromb Vasc Biol (1997) 0.87
Early cognition, communication and language in children with focal brain injury. Dev Med Child Neurol (1994) 0.86
Bilateral, reversible, selective thalamic involvement demonstrated by brain MR and acute severe neurological dysfunction with favorable outcome. Neuropediatrics (1994) 0.86
Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke. Arterioscler Thromb Vasc Biol (1996) 0.86
Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load? Eur Cytokine Netw (2001) 0.86
Measurement of the ZZ production cross section and limits on anomalous neutral triple gauge couplings in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.86
Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study). Nutr Metab Cardiovasc Dis (2003) 0.86
Search for gluinos in events with two same-sign leptons, jets, and missing transverse momentum with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.85
Is fatty liver always benign and should not consequently be treated? J Physiol Pharmacol (2013) 0.84
Haemostasis unbalance in Pugh-scored liver cirrhosis: characteristic changes of plasma levels of protein C versus protein S. Haemostasis (1994) 0.84
Retinal vein occlusion and inherited conditions predisposing to thrombophilia. Thromb Haemost (1998) 0.84
Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study. Atherosclerosis (2004) 0.84
Cardiovascular risk factors, angiotensin-converting enzyme gene I/D polymorphism, and left ventricular mass in systemic hypertension. Am J Cardiol (1999) 0.84
Thrombotic adverse events to coagulation factor concentrates for treatment of patients with haemophilia and von Willebrand disease: a systematic review of prospective studies. Haemophilia (2012) 0.84
Abnormally high circulation levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with a history of ischemic stroke. Arterioscler Thromb (1994) 0.84
Pit and fissure sealants: review of literature and application technique. Minerva Stomatol (2011) 0.84
Search for dilepton resonances in pp collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2011) 0.83
Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects. J Hum Hypertens (2005) 0.83
The effect of the interleukin-6 c/g-174 polymorphism and circulating interleukin-6 on fibrinogen plasma levels. Haematologica (2001) 0.83
Desmopressin in inherited disorders of platelet function. Haemophilia (2008) 0.83
Melanosis of the bladder: a rare endoscopic and histopathological finding. Urol Int (2007) 0.83
Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thromb Haemost (1999) 0.83
Production of fermented chestnut purees by lactic acid bacteria. Int J Food Microbiol (2012) 0.83
Familial spastic paraplegia, axonal sensory-motor polyneuropathy and bulbar amyotrophy with facial dysmorphia: new cases of Troyer-like syndrome. Eur J Paediatr Neurol (1998) 0.82
Observation of a new χ(b) state in radiative transitions to Υ(1S) and Υ(2S) at ATLAS. Phys Rev Lett (2012) 0.82
Search for scalar bottom quark pair production with the ATLAS detector in pp collisions at sqrt[s]=7 TeV. Phys Rev Lett (2012) 0.82
Compound heterozygosity (554-589 del, C515-T transition) in the platelet glycoprotein Ib alpha gene in a patient with a severe bleeding tendency. Thromb Haemost (1999) 0.82
Coronary artery disease, cerebral non-fatal ischemic stroke in retinal vein occlusion: an 8-yr follow-up. Nutr Metab Cardiovasc Dis (2010) 0.82
Search for new phenomena in tt events with large missing transverse momentum in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 0.82